Literature DB >> 20490981

Placental vasculature in health and disease.

Eliyahu V Khankin1, Caroline Royle, S Ananth Karumanchi.   

Abstract

Both angiogenesis and vasculogenesis occur during normal placental development. Additionally, the placenta undergoes a process of vascular mimicry (also referred to as pseudo-vasculogenesis) where the placental cytotrophoblasts that invade the spiral arteries convert from an epithelial to an endothelial phenotype during normal pregnancy. Failure of placental angiogenesis and pseudo-vasculogenesis during placental development has been linked to the pathogenesis of preeclampsia and related disorders such as intrauterine growth restriction. This review discusses placental vascular development during health and in disease with a focus on accumulating recent evidence that the maternal clinical syndrome of preeclampsia may be due to the result of excess antiangiogenic factors liberated by the diseased placenta. Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20490981     DOI: 10.1055/s-0030-1253453

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  14 in total

1.  2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells.

Authors:  Yan Li; Kai Wang; Qing-Yun Zou; Ronald R Magness; Jing Zheng
Journal:  Toxicology       Date:  2015-08-11       Impact factor: 4.221

2.  Maternal and neonatal separation and mortality associated with concurrent admissions to intensive care units.

Authors:  Joel G Ray; Marcelo L Urquia; Howard Berger; Marian J Vermeulen
Journal:  CMAJ       Date:  2012-10-22       Impact factor: 8.262

3.  Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole.

Authors:  Katharina R Beck; Murielle Bächler; Anna Vuorinen; Sandra Wagner; Muhammad Akram; Ulrich Griesser; Veronika Temml; Petra Klusonova; Hideaki Yamaguchi; Daniela Schuster; Alex Odermatt
Journal:  Biochem Pharmacol       Date:  2017-01-25       Impact factor: 5.858

4.  Gene-gene interactions and gene polymorphisms of VEGFA and EG-VEGF gene systems in recurrent pregnancy loss.

Authors:  Mei-Tsz Su; Sheng-Hsiang Lin; Yi-Chi Chen; Pao-Lin Kuo
Journal:  J Assist Reprod Genet       Date:  2014-03-27       Impact factor: 3.412

5.  Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast.

Authors:  K A Groesch; R J Torry; A C Wilber; R Abrams; A Bieniarz; L J Guilbert; D S Torry
Journal:  Placenta       Date:  2011-09-29       Impact factor: 3.481

6.  Signaling through FSH receptors on human umbilical vein endothelial cells promotes angiogenesis.

Authors:  Julie A Stilley; Rongbin Guan; Diane M Duffy; Deborah L Segaloff
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

7.  FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice.

Authors:  Julie A W Stilley; Debora E Christensen; Kristin B Dahlem; Rongbin Guan; Donna A Santillan; Sarah K England; Ayman Al-Hendy; Patricia A Kirby; Deborah L Segaloff
Journal:  Biol Reprod       Date:  2014-08-06       Impact factor: 4.285

Review 8.  Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.

Authors:  Camille E Powe; Richard J Levine; S Ananth Karumanchi
Journal:  Circulation       Date:  2011-06-21       Impact factor: 29.690

9.  The hemodynamic basis for positional- and inter-fetal dependent effects in dual arterial supply of mouse pregnancies.

Authors:  Tal Raz; Reut Avni; Yoseph Addadi; Yoni Cohen; Ariel J Jaffa; Brian Hemmings; Joel R Garbow; Michal Neeman
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  MicroRNAs in Human Placental Development and Pregnancy Complications.

Authors:  Guodong Fu; Jelena Brkić; Heyam Hayder; Chun Peng
Journal:  Int J Mol Sci       Date:  2013-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.